Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed
Has Results
Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: Rilonacept
2 Completed Ultrasonography in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis, Oligoarthritis;   Polyarticular Juvenile Rheumatoid Arthritis;   Systemic Juvenile Idiopathic Arthritis
Intervention: Device: Ultrasonography
3 Unknown  Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
Conditions: Purpura, Schoenlein-Henoch;   Graft Versus Host Disease;   Anemia, Hemolytic, Autoimmune;   Rheumatoid Arthritis;   Churg-Strauss Syndrome;   Hypersensitivity Vasculitis;   Wegener's Granulomatosis;   Systemic Lupus Erythematosus;   Giant Cell Arteritis;   Pure Red Cell Aplasia;   Juvenile Rheumatoid Arthritis;   Polyarteritis Nodosa;   Autoimmune Thrombocytopenic Purpura;   Takayasu Arteritis
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: filgrastim;   Drug: methylprednisolone;   Drug: prednisone;   Procedure: Autologous Peripheral Blood Stem Cell Transplantation
4 Terminated Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Interventions: Drug: Enbrel;   Drug: Placebo
5 Completed Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
Conditions: Systemic Sclerosis;   Systemic Lupus Erythematosus;   Dermatomyositis;   Juvenile Rheumatoid Arthritis;   Autoimmune Diseases
Interventions: Procedure: Stem Cell Transplantation;   Device: CD34 selection
6 Unknown  Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Systemic Lupus Erythematosus (SLE);   Dermatomyositis (DM);   DMixed Connective Tissue Disease;   Systemic Vasculitis;   Systemic Sclerosis (SSc);   Sjögren's Syndrome;   Antiphospholipid Syndrome;   Juvenile Idiopathic Arthritis;   Juvenile SLE;   Juvenile DM
Intervention: Biological: Anti-pandemic H1N1 influenza vaccine
7 Completed Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Drug: ACZ885
8 Not yet recruiting Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders
Conditions: Osteoporosis;   Juvenile Rheumatoid Arthritis;   Dermatomyositis;   Polyarthritis;   Systemic Lupus Erythematosis;   Vasculitis;   Glucocorticoid-induced Osteoporosis
Intervention: Drug: denosumab
9 Completed
Has Results
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: canakinumab;   Drug: placebo
10 Terminated
Has Results
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab;   Drug: Placebo
11 Terminated Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis
Conditions: Arthritis, Juvenile Rheumatoid;   Still's Disease, Juvenile Onset
Intervention: Biological: tocilizumab
12 Enrolling by invitation Comparative Autoantibody and Immunologic Cell Marker Study
Conditions: Autoimmune Diseases;   Lupus Erythematosus, Systemic;   Communicable Diseases
13 Unknown  Alendronate Osteoporosis Study
Condition: Glucocorticoid-Associated Osteopenia and Osteoporosis
Intervention: Drug: Alendronate
14 Recruiting Glycosylated Ferritin in Macrophagic Activation Syndromes
Conditions: Still's Disease, Adult-Onset;   Sepsis;   Macrophagic Activation Syndrome

Indicates status has not been verified in more than two years